[1] Ushigome H, Yasui M, Ohue M, et al.The treatment strategy of R0 resection in colorectal cancer with synchronous paraaortic lymph node metastasis[J]. World J Surg Oncol, 2020, 18(1): 229.
[2] Van Cttsem E, Cervantes A, et al.ESMO consensus guidelines for the management of patients with metastatic colorectal cancer[J]. Ann Oncol, 2016, 27(8): 1386-1422.
[3] Brule SY, Jonker DJ, Karapetis CS, et al.Location of coloncancer (right-sided versus left-sided) as a prognostic factor and a predictor ofbenefit from cetuximab in NCIC CO.17[J]. Eur J Cancer, 2015,51(11):1405-1414.
[4] Engstrand J,Nlsson H, Stromberg C,et al.Colorectal cancer liver metastases-apopulation-based study on incidence, management and survival[J]. BMC Cancer, 2018, 18(1):78.
[5] Raut CP, Izzo F, Marra P, et al.Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis[J]. Ann Surg Oncol, 2005, 12(8): 616-628.
[6] Amersi FF, McElrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors[J]. Arch Surg, 2006, 141(6): 581-587; discussion 581-587.
[7] Akgül Ö, Çetinkaya E, Ersöz Ş, Tez M.Role of surgery in colorectal cancer liver metastases[J]. World J Gastroenterol 2014, 20(20): 6113-6122
[8] Steele G, Bleday R, Mayer RJ, et al.A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584[J]. J Clin Oncol, 1991, 9(7): 1105-1112. |
